Feb 18 2025 28 mins
Featuring a slide presentation and related discussion from Dr Surbhi Sidana, including the following topics:
- Key clinical data of FDA-approved chimeric antigen receptor (CAR) T-cell therapies (0:00)
- Real-world evidence evaluating utility of CAR T-cell therapies in the clinic (8:08)
- Impact of prior BCMA-targeted treatment on CAR T-cell therapy efficacy (12:55)
- Investigational CAR T-cell therapies in clinical development (15:08)
- Incidence and management of toxicities associated with CAR T-cell therapy (18:21)